Qatar's Ministry of Public Health Issues Warning on Unlicensed Slimming Products Containing Undeclared Drugs

Doha, Qatar Jul 31, 2026 ALN: The Ministry of Public Health in Qatar has issued a significant warning to the public regarding the dangers posed by unlicensed slimming products, particularly highlighting a specific product known as Eatless - Natural Slimming Formula. This product has been found to contain undeclared pharmaceutical substances, which raises serious concerns about its safety and legality.

In a formal statement released by the Ministry, it was made clear that the product in question is not only unlicensed in the State of Qatar but also classified as a counterfeit due to the presence of two undeclared active ingredients: Sibutramine and Phenolphthalein. The implications of such findings are profound, as the use of these substances can pose substantial health risks to consumers. This warning is especially pertinent in a time when the demand for weight management solutions continues to rise globally, leading to an influx of various products that may not meet safety standards.

Sibutramine, a substance that was once prescribed for weight loss, was withdrawn from the market in October 2010 due to serious safety concerns. The withdrawal followed numerous reports and studies indicating that the drug could lead to significant increases in blood pressure and heart rate, among other cardiovascular issues. For individuals with pre-existing health conditions, such as coronary artery disease, congestive heart failure, arrhythmias, or a history of stroke, the consumption of Sibutramine could trigger life-threatening complications. The Ministry's warning serves as a critical reminder of the potential dangers associated with unapproved pharmaceutical substances. This situation highlights the need for ongoing vigilance and regulation within the health supplement market.

Moreover, the risks associated with Sibutramine extend beyond its immediate effects. The substance can interact negatively with other medications a patient may be taking, leading to further health complications. This potential for interaction underscores the importance of only using medications and supplements that have been properly vetted and approved by health authorities. In many cases, consumers may not be aware of the interactions between over-the-counter supplements and prescription medications, which can lead to unanticipated adverse effects.

Phenolphthalein, the second undeclared substance found in the Eatless product, is a chemical compound that has not been recognized as an active ingredient in any approved medication. Research has indicated that Phenolphthalein may be linked to an increased risk of cancer, adding another layer of concern regarding the consumption of products containing this compound. The association between Phenolphthalein and cancer risk raises alarms about the long-term health implications for consumers who may inadvertently ingest this substance. This concern is compounded by the fact that many individuals seeking weight loss solutions may be unaware of the ingredients in the products they are consuming, emphasizing the need for greater transparency in product labeling.

In light of these findings, the Ministry of Public Health has taken a proactive stance by collaborating with various relevant entities within Qatar to implement stringent control, regulatory, and legal measures against those who violate health and safety standards. This initiative aims to protect public health and ensure that consumers are not exposed to harmful products. The Ministry's commitment to safeguarding the health of its citizens is evident in its rigorous approach to monitoring the market for unlicensed and potentially dangerous products. By enhancing regulatory oversight, the Ministry hopes to deter the distribution of counterfeit products and protect the well-being of consumers.

In recent years, the rise of social media has facilitated the rapid promotion and distribution of various health and wellness products, including slimming supplements. The Ministry has specifically cautioned the public against purchasing unregistered products or those sold by unlicensed sources, particularly those that make dubious claims such as "100% natural," "safe," or "pharmaceutical-free." Such marketing tactics can be misleading and do not guarantee the safety or efficacy of the product being advertised. The allure of these claims can often lead consumers to overlook potential risks, making them more susceptible to purchasing harmful products.

The proliferation of unregulated slimming products poses a significant challenge not only for health authorities but also for consumers who may be seeking effective solutions for weight management. The allure of quick fixes and natural remedies can often cloud judgment, leading individuals to make potentially dangerous choices. Therefore, public awareness and education about the risks associated with unlicensed products are essential components of the Ministry's efforts. Educational campaigns aimed at informing the public about the dangers of unregulated supplements could help mitigate the risks associated with their use.

The Ministry's warning is a timely reminder of the importance of due diligence when it comes to health and wellness products. Consumers are encouraged to consult healthcare professionals before starting any new diet or supplement regimen, particularly those that promise rapid weight loss or miraculous health benefits. The involvement of medical professionals can provide valuable insights and help individuals make informed decisions about their health. By fostering a culture of consultation and informed decision-making, the Ministry aims to empower consumers to take charge of their health responsibly.

As the global market for dietary supplements continues to expand, the need for robust regulatory frameworks to ensure consumer safety becomes increasingly critical. The challenges posed by counterfeit and unlicensed products are not unique to Qatar; they are a global concern that necessitates coordinated efforts among countries to combat the distribution of unsafe products. International cooperation and information sharing between health authorities can play a significant role in addressing these challenges and enhancing consumer safety on a broader scale.

In conclusion, the Ministry of Public Health's warning about the Eatless - Natural Slimming Formula serves as a crucial alert to the public regarding the dangers of consuming unlicensed products containing undeclared pharmaceutical substances. The health risks associated with Sibutramine and Phenolphthalein underscore the importance of regulatory oversight and consumer vigilance. As individuals navigate the complex landscape of health and wellness products, being informed and cautious can help mitigate potential health risks and ensure overall well-being. The Ministry's proactive measures and public awareness campaigns are vital steps toward improving consumer safety and health outcomes in Qatar.